Trials / Completed

CompletedNCT00756977

BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

Status: Completed
Phase: Phase 3
Study type: Interventional
Enrollment: 394 (actual)

Sponsor: Braintree Laboratories · Industry
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

This is a randomized, parallel, multi-center, single-blind study, comparing BLI850 to an FDA approved bowel preparation in adult subjects undergoing colonoscopy.

Conditions

Colon Cancer

Interventions

Type	Name	Description
DRUG	BLI850	multi-dose preparation for oral administration prior to colonoscopy
DRUG	polyethylene glycol 3350 based bowel preparation	multi-dose preparation for oral administration prior to colonoscopy

Timeline

Start date: 2008-08-01
Primary completion: 2008-11-01
First posted: 2008-09-22
Last updated: 2013-08-15
Results posted: 2013-08-09

Locations

12 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00756977. Inclusion in this directory is not an endorsement.